SCPH

scPharmaceuticals Inc. [SCPH] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SCPH Stock Summary

In the News

SCPH Financial details

Company Rating
-
Market Cap
177.75M
Income
-56.43M
Revenue
13.59M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
135
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-4.65
Forward P/E
-
PEG
-4.09
P/S
30.04
P/B
4.95
P/C
-
P/FCF
-4.03
Quick Ratio
8.62
Current Ratio
9.53
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.47
EPS next Y
-
EPS next Q
-
EPS this Y
7.58%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
60.59%
EPS Q/Q
-10%
-
-
-
-
SMA20
-
SMA50
20%
SMA100
100%
Inst Own
-
Inst Trans
-
ROA
-49%
ROE
31%
ROC
-0.52%
Gross Margin
73%
Oper. Margin
-662%
Profit Margin
-699%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.63-12.75
52W High
-52.75%
52W Low
+41.75%
RSI
66
Rel Volume
46.38
Avg Volume
235.01K
Volume
10.9M
Perf Week
0.18%
Perf Month
2.9%
Perf Quarter
-
Perf Half Y
131.43%
-
-
-
-
Beta
0.045
-
-
Volatility
0%, 0.05%
Prev Close
0%
Price
5.67
Change
0%

Something similar

Top by Market Cap
AAPL
TL0.DE
LLY
ABEA.DE
BRK-B
Same Sector
HQY
SUVEN.NS
INIS
IDXX
SLV.WA
Same Price Range
0762.HK
VKQ
CYN
002494.SZ
600789.SS
Similar Market Cap
8426.HK
1955.HK
1399.HK
SANION.ST
ZTR

Company Profile

Healthcare Biotechnology
  • Volume Average 235.01K
  • Market Capitalization 177.75M
  • Employee 135
  • CEO Mr. John H. Tucker
  • Headquarters Burlington,MA,US
  • IPO Date 2017-11-17
  • Website https://www.scpharmaceuticals.com

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.